Leow, Jeffrey J.
University College London Hospitals NHS Foundation Trust,
United Kingdom
2025 Rank: 287278
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1825 out of 92052 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 287278 | 282818 |
| Total Cites | 363 | 415 |
| H-index | 9 | 11 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 146 | 152 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 146 | 152 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 329 | 372 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.12 |
| Self-Citation Percentage |
12.53%
|
|
Leow, Jeffrey J.
Tan Tock Seng Hospital,
Singapore
2024 Rank: 248990
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1645 out of 87532 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 248990 | 253853 |
| Total Cites | 374 | 421 |
| H-index | 10 | 11 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 141 | 148 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 141 | 148 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 340 | 381 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
11.16%
|
|
Leow, Jeffrey J.
Tan Tock Seng Hospital,
Singapore
2023 Rank: 194599
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1405 out of 82885 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 194599 | 199949 |
| Total Cites | 449 | 513 |
| H-index | 11 | 12 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 190 | 203 |
| Number of Single+First+Last Authored Papers | 50 | 50 |
| Total Cites to Single+First+Last Authored Papers | 190 | 203 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 411 | 458 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.12 |
| Self-Citation Percentage |
12.48%
|
|
Leow, Jeffrey J.
Tan Tock Seng Hospital,
Singapore
2022 Rank: 157991
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1160 out of 79729 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157991 | 164189 |
| Total Cites | 484 | 532 |
| H-index | 12 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 196 | 211 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 196 | 211 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 441 | 471 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.13 |
| Self-Citation Percentage |
9.02%
|
|
Leow, Jeffrey J.
Tan Tock Seng Hospital,
Singapore
2021 Rank: 164297
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1200 out of 76322 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 164297 | 175333 |
| Total Cites | 763 | 841 |
| H-index | 13 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 303 | 329 |
| Number of Single+First+Last Authored Papers | 45 | 45 |
| Total Cites to Single+First+Last Authored Papers | 307 | 333 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 691 | 740 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.14 |
| Self-Citation Percentage |
9.27%
|
|
Leow, Jeffrey J.
Nanyang Technological University,
Singapore
2020 Rank: 131616
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Urology & Nephrology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1018 out of 64516 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 131616 | 135421 |
| Total Cites | 620 | 696 |
| H-index | 13 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 262 | 291 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 264 | 293 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 549 | 593 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.17 |
| Self-Citation Percentage |
10.92%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.